Paper9607841
Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
Anttila M and 3 others. J Infect Dis, 1998. Cited by 126 papers, by iCite.
Cite this record
ConductScience Library. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines. Papers, record 9607841. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9607841
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Bacterial | Major topic |
| Antibody Affinity | Major topic |
| Bacterial Vaccines | Major topic |
| Immunoglobulin G | Major topic |
| Meningococcal Vaccines | Major topic |
| Polysaccharides, Bacterial | Major topic |
| Streptococcus pneumoniae | Major topic |
| Vaccines, Conjugate | Major topic |
| Diphtheria Toxoid | |
| Humans | |
| Infant | |
| Pneumococcal Vaccines | |
| Tetanus Toxoid |
Source PubMed
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40804314 | Approaches to assess new pneumococcal vaccines for immunogenicity, development and licensure. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/40804314 | PubMed |
| 40128220 | A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model. | Nat Commun | 2025 | https://conductscience.org/library/papers/40128220 | PubMed |
| 39257585 | The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines. | Front Immunol | 2024 | https://conductscience.org/library/papers/39257585 | PubMed |
| 36210249 | Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation. | Vaccine | 2022 | https://conductscience.org/library/papers/36210249 | PubMed |
| 34195422 | Booster immunization with a fractional dose of Prevnar 13 affects cell-mediated immune response but not humoral immunity in CD-1 mice. | Heliyon | 2021 | https://conductscience.org/library/papers/34195422 | PubMed |
| 30515161 | Protection Against Invasive Infections in Children Caused by Encapsulated Bacteria. | Front Immunol | 2018 | https://conductscience.org/library/papers/30515161 | PubMed |
| 30374357 | The Chlamydia M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Chlamydia muridarum Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune Responses. | Front Immunol | 2018 | https://conductscience.org/library/papers/30374357 | PubMed |
| 29299402 | Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea. | Pneumonia (Nathan) | 2017 | https://conductscience.org/library/papers/29299402 | PubMed |
| 28433580 | Description of a novel multiplex avidity assay for evaluating HPV antibodies. | J Immunol Methods | 2017 | https://conductscience.org/library/papers/28433580 | PubMed |
| 27178810 | Co-delivery of GPI-anchored CCL28 and influenza HA in chimeric virus-like particles induces cross-protective immunity against H3N2 viruses. | J Control Release | 2016 | https://conductscience.org/library/papers/27178810 | PubMed |
| 26939935 | Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses. | Clin Exp Immunol | 2016 | https://conductscience.org/library/papers/26939935 | PubMed |
| 25506706 | Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children. | PLoS One | 2014 | https://conductscience.org/library/papers/25506706 | PubMed |
| 24058629 | Characteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclasses. | PLoS One | 2013 | https://conductscience.org/library/papers/24058629 | PubMed |
| 23660844 | Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A. | Immunol Res | 2014 | https://conductscience.org/library/papers/23660844 | PubMed |
| 23378166 | Correlation of pneumococcal antibody concentration and avidity with patient clinical and immunologic characteristics. | J Clin Immunol | 2013 | https://conductscience.org/library/papers/23378166 | PubMed |
| 23153440 | Low opsonic activity to the infecting serotype in pediatric patients with invasive pneumococcal disease. | Vaccine | 2013 | https://conductscience.org/library/papers/23153440 | PubMed |
| 22285687 | Development and application of a GuHCl-modified ELISA to measure the avidity of anti-HPV L1 VLP antibodies in vaccinated individuals. | Mol Cell Probes | 2012 | https://conductscience.org/library/papers/22285687 | PubMed |
| 21628671 | Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine. | J Infect Dis | 2011 | https://conductscience.org/library/papers/21628671 | PubMed |
| 21539882 | Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months. | Vaccine | 2011 | https://conductscience.org/library/papers/21539882 | PubMed |
| 21184126 | Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients. | Eur J Clin Microbiol Infect Dis | 2011 | https://conductscience.org/library/papers/21184126 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9607841
GET https://conductscience.org/api/papers/v1/9607841/cited_by?page=2